Ulcerative Colitis Market to Reach USD 17.82 Billion by 2035 at 4.68% CAGR
Ulcerative Colitis Market Overview The Ulcerative Colitis Market is expanding as the global burden of inflammatory bowel disease increases and treatment approaches continue to evolve. Ulcerative colitis therapies range from established aminosalicylates and corticosteroids to immunomodulators, biologics, JAK inhibitors, and newer targeted therapies. Growing diagnosis rates, broader reimbursement, biosimilar competition, and advances in precision treatment … Read more